000			01831 a2200529 4500
005			20250516150350.0
264		0	_c20131223
008			201312s 0 0 eng d
022			_a1872-8227
024	7		_a10.1016/S0168-8227(13)70005-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aBebakar, Wan Mohamad Wan
245	0	0	_aSafety and effectiveness of insulin aspart in type 2 diabetic patients: results from the ASEAN cohort of the A₁chieve study. _h[electronic resource]
260			_bDiabetes research and clinical practice _cApr 2013
300			_aS17-23 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Observational Study
650	0	4	_aAged
650	0	4	_aAsia, Southeastern _xepidemiology
650	0	4	_aAsian People
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Glucose _xdrug effects
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aFemale
650	0	4	_aGlycated Hemoglobin _xmetabolism
650	0	4	_aHumans
650	0	4	_aHypoglycemia _xblood
650	0	4	_aHypoglycemic Agents _xadverse effects
650	0	4	_aInsulin Aspart _xadverse effects
650	0	4	_aLipids _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrevalence
650	0	4	_aProspective Studies
650	0	4	_aQuality of Life
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aWeight Gain _xdrug effects
700	1		_aLim-Abrahan, Mary Anne
700	1		_aJain, Ananá B
700	1		_aSeah, Darren
700	1		_aSoewondo, Pradana
773	0		_tDiabetes research and clinical practice _gvol. 100 Suppl 1 _gp. S17-23
856	4	0	_uhttps://doi.org/10.1016/S0168-8227(13)70005-6 _zAvailable from publisher's website
999			_c22727746 _d22727746